Search

Your search keyword '"Caissie, Amanda"' showing total 128 results
Start Over Author "Caissie, Amanda" Language english
128 results on '"Caissie, Amanda"'

1. Operational Ontology for Oncology (O3): A Professional Society-Based, Multistakeholder, Consensus-Driven Informatics Standard Supporting Clinical and Research Use of Real-World Data From Patients Treated for Cancer

Author

Mayo, Charles S., Feng, Mary U., Brock, Kristy K., Kudner, Randi, Balter, Peter, Buchsbaum, Jeffrey C., Caissie, Amanda, Covington, Elizabeth, Daugherty, Emily C., Dekker, Andre L., Fuller, Clifton D., Hallstrom, Anneka L., Hong, David S., Hong, Julian C., Kamran, Sophia C., Katsoulakis, Eva, Kildea, John, Krauze, Andra V., Kruse, Jon J., McNutt, Tod, Mierzwa, Michelle, Moreno, Amy, Palta, Jatinder R., Popple, Richard, Purdie, Thomas G., Richardson, Susan, Sharp, Gregory C., Satomi, Shiraishi, Tarbox, Lawrence R., Venkatesan, Aradhana M., Witztum, Alon, Woods, Kelly E., Yao, Yuan, Farahani, Keyvan, Aneja, Sanjay, Gabriel, Peter E., Hadjiiski, Lubomire, Ruan, Dan, Siewerdsen, Jeffrey H., Bratt, Steven, Casagni, Michelle, Chen, Su, Christodouleas, John C., DiDonato, Anthony, Hayman, James, Kapoor, Rishhab, Kravitz, Saul, Sebastian, Sharon, Von Siebenthal, Martin, Bosch, Walter, Hurkmans, Coen, Yom, Sue S., and Xiao, Ying

Published
2023
Full Text
View/download PDF

7. 2851: Operational Ontology for Oncology (O3) - Multi-professional society standard supporting AI

Author

Mayo, Charles S., Feng, Mary U., Brock, Kristy K., Kudner, Randi, Balter, Peter, Buchsbaum, Jeffrey, Caissie, Amanda, Daugherty, Emily, Dekker, Andre, Fuller, Clifton D., Hong, Julian, Hong, David, Kamran, Sophia, Katsoulakis, Evangelia, Kildea, John, Krauze, Andra, Kruse, Jon, McNutt, Todd, Mierzwa, Michelle, Moreno, Amy, Palta, Jatinder, Popple, Richard, Purdie, Thomas, Yom, Susan, and Ying, Xiao

Published
2024
Full Text
View/download PDF

8. Directly Improving the Quality of Radiation Treatment Through Peer Review: A Cross-sectional Analysis of Cancer Centers Across a Provincial Cancer Program

Author

Czarnota, Gregory, El-Mallah, Medhat, Falkson, Conrad, Liu, Fei-Fei, Gulavita, Sunil, McMillan, William, Pantarotto, Jason, Rachakonda, Ramana, Read, Nancy, Schneider, Ken, Shehata, Sarwat, Stevens, Christiaan, Tsao, Jonathan, Waldron, John, Wells, Woodrow, Wright, Jim, Warde, Padraig, Sharpe, Michael, Lockhart, Elizabeth, Brundage, Michael, Hart, Margaret, Caissie, Amanda, Hollenhorst, Helmut, Wilson, Lianne, Parliament, Matthew, Milosevic, Michael, Halperin, Ross, Foxcroft, Sophie, Ebacher, Annie, McGowan, Thomas, Rouette, Julie, Gutierrez, Eric, O'Donnell, Jennifer, Reddeman, Lindsay, Mitera, Gunita, and Brundage, Michael D.

Published
2017
Full Text
View/download PDF

19. Striving to Fill in Gaps between Clinical Practice and Standards: The Evolution of a Pan-Canadian Approach to Patient-Reported Outcomes Use.

Author

Caissie, Amanda, Olson, Robert, Barbera, Lisa, O'Donnell, Jennifer, Davis, Carol-Anne, Croke, Jennifer, Bird, Louise, Kildea, John, Brown, Erika, Brundage, Michael, and Milosevic, Michael

Subjects
*CLINICAL trials, *RADIOTHERAPY, *RADIATION, *BIG data, *SURVIVAL rate
Abstract

Despite the known importance and necessity of the standardized collection and use of patient-reported outcomes (PROs), there remain challenges to successful clinical implementation. Facilitated through a quality improvement initiative spearheaded by the Canadian Partnership for Quality Radiotherapy (CPQR), and now guided by the Canadian Association of Radiation Oncology (CARO)'s Quality and Standards Committee, patient representatives and early-adopter radiation treatment programs continue to champion the expansion of PROs initiatives across the country. The current review discusses the evolution of a pan-Canadian approach to PROs use, striving to fill in gaps between clinical practice and guideline recommendations through multi-centre and multidisciplinary collaboration. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

30. In Reply to Wang and Rallis

Author

Kang, Stella, Caissie, Amanda, Kassam, Zahra, Ingledew, Paris-Ann, Alfieri, Joanne, Parliament, Matthew, Bezjak, Andrea, and Giuliani, Meredith

Published
2021
Full Text
View/download PDF

37. Improving patient outcomes and radiotherapy systems: A pan‐Canadian approach to patient‐reported outcome use.

Author

Caissie, Amanda, Brown, Erika, Olson, Rob, Barbera, Lisa, Davis, Carol‐Anne, Brundage, Michael, and Milosevic, Michael

Subjects
*HEALTH outcome assessment, *RADIOTHERAPY, *STANDARDIZATION, *MEDICAL care, *RADIOTHERAPY treatment planning
Abstract

Standardized collection and use of clinical patient‐reported outcomes (PRO) have potential to benefit the care of individual patients and improve radiotherapy system performance. Its centralized health‐care system makes Canada a prime candidate to take a leader and collaborator role in international endeavors to promote expansion of patient‐reported outcome collection and use in radiotherapy. The current review discusses the development of a pan‐Canadian approach to PRO use, through a quality improvement initiative led by the Canadian Partnership for Quality Radiotherapy (CPQR), a unique partnership of Canadian radiotherapy professional organizations (Canadian Association of Radiation Oncology‐CARO, Canadian Organization of Medical Physicists‐COMP, and the Canadian Association of Medical Radiation Technologists‐CAMRT). [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

38. Performance/outcomes data and physician process challenges for practical big data efforts in radiation oncology.

Author

Matuszak, Martha M., Fuller, Clifton D., Yock, Torunn I., Hess, Clayton B., McNutt, Todd, Jolly, Shruti, Gabriel, Peter, Mayo, Charles S., Thor, Maria, Caissie, Amanda, Rao, Arvind, Owen, Dawn, Smith, Wade, Palta, Jatinder, Kapoor, Rishabh, Hayman, James, Waddle, Mark, Rosenstein, Barry, Miller, Robert, and Choi, Seungtaek

Subjects
BIG data, RADIOTHERAPY, PERFORMANCE evaluation, HEALTH outcome assessment, ONCOLOGY
Abstract

It is an exciting time for big data efforts in radiation oncology. The use of big data to help aid both outcomes and decision‐making research is becoming a reality. However, there are true challenges that exist in the space of gathering and utilizing performance and outcomes data. Here, we summarize the current state of big data in radiation oncology with respect to outcomes and discuss some of the efforts and challenges in radiation oncology big data. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

40. The effects of a cyclooxygenase-2 (COX-2) expression and inhibition on human uveal melanoma cell proliferation and macrophage nitric oxide production

Author

Marshall Jean-Claude, Caissie Amanda, Cruess Stephanie, Cools-Lartigue Jonathan, and Burnier Miguel

Subjects
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282
Abstract

Background Cyclooxygenase-2 (COX-2) expression has previously been identified in uveal melanoma although the biological role of COX-2 in this intraocular malignancy has not been elucidated. This study aimed to investigate the effect of a COX-2 inhibitor on the proliferation rate of human uveal melanoma cells, as well as its effect on the cytotoxic response of macrophages. Methods Human uveal melanoma cell lines were transfected to constitutively express COX-2 and the proliferative rate of these cells using two different methods, with and without the addition of Amfenac, was measured. Nitric oxide production by macrophages was measured after exposure to melanoma-conditioned medium from both groups of cells as well as with and without Amfenac, the active metabolite of Nepafenac. Results Cells transfected to express COX-2 had a higher proliferation rate than those that did not. The addition of Amfenac significantly decreased the proliferation rate of all cell lines. Nitric oxide production by macrophages was inhibited by the addition of melanoma conditioned medium, the addition of Amfenac partially overcame this inhibition. Conclusion Amfenac affected both COX-2 transfected and non-transfected uveal melanoma cells in terms of their proliferation rates as well as their suppressive effects on macrophage cytotoxic activity.

Published
2007

44. 183: Head and Neck Radiotherapy (RT) Patterns of Practice Variability Identified as a Challenge to Real-World Big Data: Recommendations from the Learning from Analysis of Multicentre Big Data Aggregation (Lambda) Consortium.

Author

Caissie, Amanda, Mierzwa, Michelle, Fuller, Clifton, Rajaraman, Murali, Lin, Alex, MacDonald, Andrew, Popple, Richard, Xiao, Ying, VanDijk, Lisanne, Balter, Peter, Fong, Helen, Ping, Heng, Lee, Joonsan, Rao, Arvind, Martel, Mary, Thompson, Reid, Yao, John, and Mayo, Chuck

Subjects
*BIG data, *CONSORTIA, *NECK, *RADIOTHERAPY, *LEARNING
Published
2020
Full Text
View/download PDF

45. Relationship between histopathological features of chemotherapy treated retinoblastoma and P-glycoprotein expression.

Author

Souza Filho, João P., Martins, Maria C., Caissie, Amanda L., Torres, Virginia L. L., Fernandes, Luiza H. C. F., Erwenne, Clelia M., and Burnier Jr., Miguel N.

Subjects
RETINOBLASTOMA, RETINA cancer, DRUG therapy, P-glycoprotein, GLYCOPROTEINS, GLYCOCONJUGATES, CANCER treatment
Abstract

Background: P-glycoprotein (P-gp) has been identifiedas a possible mediator of chemoresistance in retinoblastoma. Theaim of this study was to determine the expression of P-gp in retinoblastomatreated with chemotherapy prior to enucleation.Methods: Seventeen enucleated specimens of retinoblastomafrom 16 patients were studied. Nine had been treated with chemotherapyalone, and eight had been treated with chemotherapy and other formsof local treatment. Tumour differentiation as well as choroidaland optic nerve invasion were assessed. P-gp immunohistochemicalstaining was performed and evaluated as negative, low or high.Results: Histopathological assessment of thecases showed that 14 of 17 eyes (82.3%) had viable retinoblastomacells. Nine retinoblastomas were considered regressed with a well-differentiatedcomponent, five regressed retinoblastomas had viable cells withpoor differentiation and three retinoblastomas had regressed leavingno viable cells. Sixteen of 17 retinoblastomas were P-gp positive.In the one case with optic nerve invasion and the three cases with massivechoroidal invasion, P-gp expression was found in invading retinoblastomacells.Conclusion: Almost all retinoblastomas expressedP-gp. High levels of P-gp expression might play a role in chemotherapyresistance of retinoblastoma or, conversely, chemotherapymight induce P-gp expression. These results might have an impacton management of bilateral retinoblastoma. [ABSTRACT FROM AUTHOR]

Published
2005
Full Text
View/download PDF

47. Contributors

Author

Abernethy, Amy P., Adler, Douglas G., Alici, Yesne, Balagula, Eugene, Balmanoukian, Ani, Banerjee, Nikhil, Becker, Gerhild, Boquiren, Virginia, Brahmer, Julie R., Breitbart, William, Brennan, Michael T., Bruera, Eduardo, Brydøy, Marianne, Buckman, Robert, Caissie, Amanda, Carver, Joseph R., Chochinov, Harvey M., Chow, Edward, Chua, Ai-Ping, Clark, Maureen E., Correa, Raimundo, Courneya, Kerry S., Currow, David C., Dalal, Shalini, Davis, Mellar P., de Wit, Maike, Dhillon, Haryana, Dicato, Mario, Diel, Ingo J., Dodge, Jason E., Doolittle, Matthew, Dörr, Wolfgang, Dunn, Geoffrey P., Easson, Alexandra M., Ernst, Edzard K., Feyer, Petra Ch., Fogelman, David R., Fosså, Sophie D., Freedman, Orit, Friedman, Debra L., Gebreselassie, Surafel, Gildea, Thomas R., Giovannini, Marc, Glare, Paul A., Greene, Arin K., Hardy, Janet R., Hinshaw, Daniel B., Hoeller, Ulrike, Hou, Juliet, Jedlicka, Lynn, Jensen, Siri Beier, Johnston, Katherine T., Jones, Jason M., Jordan, Karin, Karuppasamy, Karunakaravel, Kikano, Raghid, Kirsh, Kenneth L., Kiserud, Cecilie, Kissane, David W., Krajnik, Małgorzata, Kramm, Christof, Kwok, Sheldon, Lacouture, Mario E., Levitin, Abraham, Li, Madeline, Librach, S. Lawrence, Lichtenthal, Wendy G., Lieberman, Isador, Lin, Vernon W.H., Link, Hartmut, Lo, Christopher, Lopes, César V., Loprinzi, Charles L., Lowery, Amy E., Mader, Robert, Magelssen, Henriette, Maida, Vincent, Marsman, H.A., McClement, Susan E., McGowan, Erin L., Moskovic, Daniel J., Newman, Marissa, Nikolova, Tanya, Oldenburg, Jan, Ortner, Petra, Pachman, Dierdre R., Pang, Jocelyn, Passik, Steven D., Pawlik, Timothy M., Pereira-Lima, Júlio C., Peterson, Douglas E., Piper, Barbara F., Plawny, Laurent, Pope, Kathy, Potter, Jennifer, Prigerson, Holly G., Ripamonti, Carla I., Robles, Lizbeth, Rodin, Gary, Ruppert, Lisa, Sabo, Brenda M., Salvo, Nadia, Santacruz, Jose Fernando, Savard, Josée, Schook, Carolyn C., Shepard, Dale R., Shepherd, Heather L., Slavin, Sumner A., Smith, Martin L., Spijkervet, Fred K.L., Stevens, Glen H.J., Stubblefield, Michael D., Sykes, Nigel P., Tam, Matthew, Tattersall, Martin H.N., Vachon, Mary L.S., van der Pool, A.E., van Gulik, T.M., Vardy, Janette, Verhoef, Cornelis, Vissink, Arjan, Wolf, Hans-Heinrich, Wong, Rebecca K.S., Zimmermann, Camilla, and Zylicz, Zbigniew

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results